Meditext Information

Meditext: Turning Diagnosis into Scalable Revenue and Patient Action Meditext is a patent-pending patient activation platform that transforms ICD-10 diagnosis data into compliant, automated outreach—creating revenue and outcomes where both are typically lost. With no apps, no logins, and no disruption, Meditext connects patients to provider-recommended actions—scheduling, care plans, and products—via secure, 1-click SMS. Just as Uber turned idle cars into income, Meditext turns idle diagnosis codes into action. It operates entirely on the systems providers already run, enabling clinical teams to triage entire patient panels in real-time—without adding staff, software, or friction. It is the inevitable solution to a global problem: health systems are overwhelmed, understaffed, and losing billions annually due to care gaps and follow-through failures. Meditext automatically identifies care gaps, prioritizes outreach based on ICD-10 severity, and links patients to real next steps—from follow-up appointments to condition-specific devices and services. Through targeted CPC and CPM-based campaigns, Meditext also unlocks a novel, sustainable revenue stream from private industry advertisers and diagnosis-matched product partners. Results are real: adherence boosts up to 45%, readmissions cut by up to 30%, and millions in new revenue generated at scale. Meditext can handle billions of ICD-10 codes and is globally deployable across all diagnosis-based care systems. In short, Meditext offers what today’s systems desperately need: automated activation, compliant monetization, and zero operational burden. It bridges healthcare with private-sector scalability—finally transforming diagnosis into direction, and cost centers into revenue engines.